Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Photodegradation kinetics of Bilastine in tablets

View through CrossRef
Photodegradation is the process by which a chemical substance is broken down through exposure to light, typically ultraviolet (UV) radiation. This process is significant in environmental chemistry, where sunlight can degrade pollutants and materials, influencing their persistence and toxicity. Bilastine is a novel non-sedating histamine H1-receptor antagonist developed for the treatment of allergic rhino conjunctivitis and urticaria. The literature presents some studies on the quantitative determination of bilastine by high-performance liquid chromatography in pharmaceutical forms and biological fluids, however, no data on the photodegradation kinetics of this drug are described. Therefore, the objective of the study was to determine the photodegradation kinetics of the drug bilastine in coated tablets using a liquid chromatography method previously developed and validated by the same research group (unplished data). The study was carried out with methanolic solution containing 100.0 mg mL-1 of bilastine drug product exposed to UV-C radiation (254 nm). The irradiation of the samples was done at pre-established times: 0, 15, 30, 60, 120 and 180 minutes. The chromatographic separation was performed in a Shim-pack® RP-18 column; the mobile phase comprising a mixture of 0.3% triethylamine (pH adjusted to 6.0 with 20% formic acid) and acetonitrile (66:34, v/v) at a flow-rate of 1.0 mL min-1 with isocratic elution. The temperature was set at 25 °C in the column oven. Bilastine was determined by UV detection at 207 nm using photodiode-array. The results demonstrated that the photodegradation kinetics of bilastine in methanolic solution follows the first order of reaction, with a t90% of 27.11 minutes and degradation rate constant (k) of 0.0007 min-1.
Title: Photodegradation kinetics of Bilastine in tablets
Description:
Photodegradation is the process by which a chemical substance is broken down through exposure to light, typically ultraviolet (UV) radiation.
This process is significant in environmental chemistry, where sunlight can degrade pollutants and materials, influencing their persistence and toxicity.
Bilastine is a novel non-sedating histamine H1-receptor antagonist developed for the treatment of allergic rhino conjunctivitis and urticaria.
The literature presents some studies on the quantitative determination of bilastine by high-performance liquid chromatography in pharmaceutical forms and biological fluids, however, no data on the photodegradation kinetics of this drug are described.
Therefore, the objective of the study was to determine the photodegradation kinetics of the drug bilastine in coated tablets using a liquid chromatography method previously developed and validated by the same research group (unplished data).
The study was carried out with methanolic solution containing 100.
0 mg mL-1 of bilastine drug product exposed to UV-C radiation (254 nm).
The irradiation of the samples was done at pre-established times: 0, 15, 30, 60, 120 and 180 minutes.
The chromatographic separation was performed in a Shim-pack® RP-18 column; the mobile phase comprising a mixture of 0.
3% triethylamine (pH adjusted to 6.
0 with 20% formic acid) and acetonitrile (66:34, v/v) at a flow-rate of 1.
0 mL min-1 with isocratic elution.
The temperature was set at 25 °C in the column oven.
Bilastine was determined by UV detection at 207 nm using photodiode-array.
The results demonstrated that the photodegradation kinetics of bilastine in methanolic solution follows the first order of reaction, with a t90% of 27.
11 minutes and degradation rate constant (k) of 0.
0007 min-1.

Related Results

A Validated Stability Indicating HPTLC Method for Bilastine and Montelukast in Pharmaceutical Dosage Form
A Validated Stability Indicating HPTLC Method for Bilastine and Montelukast in Pharmaceutical Dosage Form
An accurate and precise and robust method has been described for Stability Indicating HPTLC method for development and validation for Bilastine and Montelukast in pharmaceutical do...
Chewable Tablets: A Comprehensive Review
Chewable Tablets: A Comprehensive Review
Tablets that can be chewed between the teeth must be broken before consumption. These tablets are provided to individuals who like swallowing and to youngsters who have difficulty ...
Factor VIII Antibodies Demonstrate Type I or Type II Kinetics in Acquired Haemophilia A
Factor VIII Antibodies Demonstrate Type I or Type II Kinetics in Acquired Haemophilia A
ABSTRACTBackgroundAcquired haemophilia A (AHA) is an acquired bleeding disorder resulting from autoantibodies against Factor VIII (FVIII). Previous studies have reported difference...
Formulation development of chewable tablets containing Phyllanthus emblica Linn. fruit extract by direct compression
Formulation development of chewable tablets containing Phyllanthus emblica Linn. fruit extract by direct compression
Indian gooseberry (Phyllanthus emblica Linn.), a plant in family Euphobiaceae, is a tree growing in tropical parts of Southeast Asia. Its fruits have been widely used in folk medic...
A History of Lost Tablets
A History of Lost Tablets
Abstract This study examines a recurrent scenario in Roman poetry of the first-person genres: the separation of the poet from his writing tablets. Catullus' tablets are stolen (c.4...
Vibrational spectroscopy to monitor controlled drug release from hydrophilic matrices
Vibrational spectroscopy to monitor controlled drug release from hydrophilic matrices
Approximately 40% of drugs currently marketed and 90% of all drugs under development show poor and varied aqueous solubility at the different pH values encountered along the gastro...

Back to Top